Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

著者: K. Yamazaki, Michitaka Nagase, H Tamagawa, Shinya Ueda, Takao Tamura, K. Murata, Takako Eguchi Nakajima, Eishi Baba, Masahiro Tsuda, Toshikazu Moriwaki, Taito Esaki, Yasushi Tsuji, Kei Muro, Koichi Taira, Tadamichi Denda, Sadao Funai, Katsunori Shinozaki, Hitoshi Yamashita, Naotoshi Sugimoto, Tatsuya Okuno, Tomohiro Nishina, M. Umeki, Takayuki Kurimoto, Tetsuji Takayama, Akihito Tsuji, Miki Yoshida, A. Hosokawa, Yoshihiro Shibata, Koichi Suyama, Masaru Okabe, Koichi Suzuki, Narihito Seki, Kentaro Kawakami, Mikio Sato, Koshi Fujikawa, T. Hirashima, Takaya Shimura, K. Taku, Toshio Otsuji, F. Tamura, Eiji Shinozaki, Kazutaka Nakashima, Hiroki Hara, Takahiro Tsushima, Masahiko Ando, Satoshi Morita, Narikazu Boku, Ichinosuke Hyodo - Annals of Oncology 2016 被引用: 282